- 2023
- Awarded KRW 1.5 bn in government funding for its technology to develop nanotherapeutics
- Nanoparticle significantly reduces hypoxia, which is associated with poor prognosis of cancer patients
- 2020
- Established DR.CURE based on prior research outcomes and IPs
- 2019
- Carried out government-funded research to nurture innovative physician-scientists
- Fundamental works for radiotherapeutic effects on colorectal and hepatic cancers
- 2007
- Started collaborative work by running co-lab between Prof. Park IK and Prof. Jeong
- Research were focused on drug delivery system/ nanoparticle for controlling reactive oxygen species/ photothermal therapy
Scroll to top
